NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

What to Watch in the Day Ahead - Wednesday, Oct 7

Published 2015-10-06, 02:37 p/m
© Reuters.  What to Watch in the Day Ahead - Wednesday, Oct 7
SAB
-
SYENF
-
STZ
-
MON
-

(The Day Ahead is an email and PDF publication that includes the day's major stories and
events, analyses and other features. To receive The Day Ahead, Eikon users can register at
DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT)

Monsanto (NYSE:MON) Co, the world's largest seed company, reports fourth-quarter results after a failed
effort to acquire rival Syngenta AG (SIX:SYNN).

Beer maker Constellation Brands Inc (NYSE:STZ) is likely to report its second-quarter profit and sales
slightly above analysts' average estimates, according to StarMine. The company is expected to
have had strong sales of its flagship Corona brand, helped by the re-launch of the Corona Extra
can with new packaging and the introduction of 18 and 24 packs. Investors will be looking out
for commentary on a possible mega-deal between Anheuser-Busch and SABMiller (LONDON:SAB).

The Federal Reserve will issue the consumer credit figures for August. The outstanding credit
extended to American consumers probably rose $19 billion in August. (1500/1900) The Mortgage
Bankers Association will release its index of mortgage activity for the week ended Oct. 2.
(0700/1100)

The Nobel Prize for chemistry will be announced in Stockholm. Among the contenders for the
prestigious award are Emmanuelle Charpentier of Helmholtz Center for Infection Research in
Germany and Jennifer Doudna of the University of California, the scientists behind the
technology called CRISPR-Cas9 that allows researchers to edit any gene. Other contenders for the
prize include John Goodenough of the University of Texas in Austin and Stanley Whittingham of
Binghamton University in New York for research leading to the development of the lithium-ion
battery. Also in contention is Carolyn Bertozzi of Stanford University for her contributions to
"bioorthogonal chemistry," which refers to chemical reactions in live cells and organisms.
Bertozzi's lab is using the process to develop smart probes for medical imaging.

Canadian building permits issued in August are expected to have increased 0.8 percent, having
decreased 0.6 percent in July. (0830/1230)

Enbridge Inc, Canada's largest pipeline company, holds its annual investor day in Toronto,
giving the business outlook for the company at a time when most of its customers are struggling
with low oil prices and trying to convince service providers to share the pain. Investors will
also be looking out for an estimated date for Enbridge's long-awaited Line 9 pipeline.

Greece's new left-right coalition government faces its first test in a vote of confidence. The
government controls 155 MPs in the 300-seat parliament and is expected to easily pass the vote.

Inflation in Brazil as measured by the IGP-DI price index is expected to have risen 1.23 percent
in September, compared with a 0.4 percent gain in August. Chile is expected to have posted a
trade surplus of $50 million in September.

LIVECHAT - Energy Focus with Peter Kiernan, lead energy analyst, EIU
With no signs of respite for beleaguered oil prices, we talk to Peter Kiernan, lead energy
analyst at the Economist Intelligence Unit at 0500 ET/0900 GMT about the outlook for the
industry and the knock-on effects to regional economies. To join the Global Markets Forum, click
here http://bit.ly/1kTxdKD

(Compiled By Nayyar Rasheed in Bengaluru; Edited by Don Sebastian)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.